News RSS Bioethics News.

10/05/2017

Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment

External Link - Source: Kaiser Health News

People who are incarcerated face an even tougher battle to get treatment for hepatitis C. Roughly 17 percent of prisoners are infected with hepatitis C, compared with about 1 percent of the general population. Lawyers in a handful of states are pursuing class action lawsuits to force prisons to provide hepatitis C treatment. Mavyret may make a difference, said David Rudovsky, a civil rights lawyer who’s litigating a class action lawsuit against the Pennsylvania Department of Corrections.

This entry was posted in Health Policy & Insurance, Justice and tagged , . Bookmark the permalink.